Endothelial plasminogen activator inhibitor (PAI-1) controls vascular remodeling, angiogenesis and fibrinolysis. PAI-1 blood levels in women are related to estrogen. The aim of this study was to characterize the signaling pathways through which estrogen regulates PAI-1 in endothelial cells. Furthermore, we aimed to investigate whether PAI-1 is implicated in the control of endothelial migration by estrogen. Cultured human umbilical vein endothelial cells (HUVECs) and ovariectomized rats were used to test the effects of 17b-estradiol (E2) on PAI-1 expression and its role on endothelial migration. At physiological concentrations, E2 increases the expression of PAI-1 in HUVEC within 6–12 h through activation of a signaling cascade initiated by estrogen receptor a and involving G proteins, phosphatidylinositol-3-OH kinase and Rho-associated kinase II. ROCK-II activation turns into an over-expression of c-Jun and c-Fos that is required for E2-induced expression of PAI-1. Estrogen-induced PAI-1 expression is implicated in HUVEC horizontal migration. PAI-1 regulation is found also in vivo, in female rats, where ovariectomy is associated with reduced PAI-1 expression, while estrogen replacement counteracts this change. In conclusion, E2 increases PAI-1 synthesis in human endothelial cells and in rodent aorta through a G protein-initiated signaling that targets earlyimmediate gene expression. This regulatory pathway is implicated in endothelial cell migration. These findings describe new mechanisms of action of estrogens in the vessels, which may be important for vascular remodeling and hemostasis.
|Data di pubblicazione:||2012|
|Titolo:||Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1)|
|Autori:||Gopal S; Garibaldi S; Goglia L; Polak K; Palla G; Spina G; Genazzani AR; Genazzani AD; Simoncini T|
|Digital Object Identifier (DOI):||10.1093/molehr/gas011|
|Appare nelle tipologie:||Articolo su rivista|
File in questo prodotto:
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris